"T-Lymphocytes" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen.
Descriptor ID |
D013601
|
MeSH Number(s) |
A11.118.637.555.567.569 A15.145.229.637.555.567.569 A15.382.490.555.567.569
|
Concept/Terms |
T-Lymphocytes- T-Lymphocytes
- T Lymphocytes
- T-Lymphocyte
- T-Cells
- T Cells
- T-Cell
- Thymus-Dependent Lymphocytes
- Lymphocyte, Thymus-Dependent
- Lymphocytes, Thymus-Dependent
- Thymus Dependent Lymphocytes
- Thymus-Dependent Lymphocyte
|
Below are MeSH descriptors whose meaning is more general than "T-Lymphocytes".
Below are MeSH descriptors whose meaning is more specific than "T-Lymphocytes".
This graph shows the total number of publications written about "T-Lymphocytes" by people in this website by year, and whether "T-Lymphocytes" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 13 | 13 | 26 |
1995 | 19 | 15 | 34 |
1996 | 18 | 6 | 24 |
1997 | 21 | 11 | 32 |
1998 | 22 | 14 | 36 |
1999 | 16 | 13 | 29 |
2000 | 23 | 15 | 38 |
2001 | 18 | 13 | 31 |
2002 | 26 | 16 | 42 |
2003 | 31 | 24 | 55 |
2004 | 32 | 24 | 56 |
2005 | 37 | 32 | 69 |
2006 | 42 | 25 | 67 |
2007 | 39 | 39 | 78 |
2008 | 32 | 30 | 62 |
2009 | 33 | 22 | 55 |
2010 | 32 | 32 | 64 |
2011 | 38 | 31 | 69 |
2012 | 40 | 24 | 64 |
2013 | 32 | 24 | 56 |
2014 | 35 | 8 | 43 |
2015 | 45 | 19 | 64 |
2016 | 34 | 24 | 58 |
2017 | 49 | 43 | 92 |
2018 | 49 | 22 | 71 |
2019 | 37 | 28 | 65 |
2020 | 48 | 34 | 82 |
2021 | 36 | 52 | 88 |
2022 | 13 | 42 | 55 |
2023 | 11 | 68 | 79 |
2024 | 1 | 8 | 9 |
To return to the timeline,
click here.
Below are the most recent publications written about "T-Lymphocytes" by people in Profiles.
-
Durable immunity to EBV after rituximab and third-party LMP-specific T cells: a Children's Oncology Group study. Blood Adv. 2024 Mar 12; 8(5):1116-1127.
-
Autophagy differentially regulates tissue tolerance of distinct target organs in graft-versus-host disease models. J Clin Invest. 2024 Mar 01; 134(5).
-
Nanofibrous MultiDomain Peptide Hydrogels Provide T Cells a 3D, Cytocompatible Environment for Cell Expansion and Antigen-Specific Killing. ACS Biomater Sci Eng. 2024 Mar 11; 10(3):1448-1460.
-
Peptide-scFv antigen recognition domains effectively confer CAR T?cell multiantigen specificity. Cell Rep Med. 2024 Feb 20; 5(2):101422.
-
Flow cytometry quantification of tumor-infiltrating lymphocytes to predict the survival of patients with diffuse large B-cell lymphoma. Front Immunol. 2024; 15:1335689.
-
Bispecific BCMA/CD24 CAR-T cells control multiple myeloma growth. Nat Commun. 2024 Jan 19; 15(1):615.
-
Is immune escape in the rearview mirror? Blood. 2024 Jan 11; 143(2):97-98.
-
LncRNA Malat1 suppresses pyroptosis and T cell-mediated killing of incipient metastatic cells. Nat Cancer. 2024 Feb; 5(2):262-282.
-
Immuno-Oncology: New Insights into Targets and Therapies. Surg Oncol Clin N Am. 2024 Apr; 33(2):265-278.
-
GD2-CAR CAR T?cells in patients with osteosarcoma and neuroblastoma-it's not only the T cells that matter. Cancer Cell. 2024 01 08; 42(1):8-10.